Skip to content
Pharma Observatory a Scientist.com platform

Condition (MeSH)

Otosclerosis

ClinicalTrials.gov lists 23 trials for Otosclerosis or a narrower condition beneath it. Fondation Ophtalmologique Adolphe de Rothschild has the most among industry and government lead sponsors, with 3.

MeSH D010040 Otorhinolaryngologic Diseases C09 Listed by Orphanet as a rare disease
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Phase 3 Phase 3 1 Phase 4 Phase 4 1 Not applicable Not applicable 8 Observational Observational 13 Phase 3 Phase 3 1 Phase 4 Phase 4 1 Not applicable Not applicable 8 Observational Observational 13

Trials per phase

23 of the 23 trials are tagged with Otosclerosis itself; the rest are tagged with a narrower condition beneath it.

Get the Otosclerosis report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

When did Otosclerosis trials start? (11)

Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.

Trials over time, by phase

  • Phase 3
  • Phase 4
  • Not applicable
  • Observational

Top of scale: 4

2002: 1 trials (Observational 1) 2007: 1 trials (Phase 4 1) 2012: 2 trials (Not applicable 1, Phase 3 1) 2014: 3 trials (Observational 2, Not applicable 1) 2015: 2 trials (Not applicable 2) 2019: 1 trials (Observational 1) 2021: 2 trials (Observational 2) 2022: 3 trials (Observational 2, Not applicable 1) 2023: 3 trials (Observational 2, Not applicable 1) 2024: 4 trials (Observational 3, Not applicable 1) 2025: 1 trials (Not applicable 1)

Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.

Trials started per year
Year Trials started
2025 1
2024 4
2023 3
2022 3
2021 2
2019 1
2015 2
2014 3
2012 2
2007 1

No forecast is made for this condition: it averages 2.4 trial starts a year over the five years to September, under the 5 a year the method needs.

Recruitment duration, a model prediction: 1 trial still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.

What phase are Otosclerosis trials in? (4)

Shown in this order: phase order.

Show the trials by phase as a table
Trials by phase
Phase Trials
Phase 3 1
Phase 4 1
Not applicable 8
Observational 13

How many Otosclerosis trials are recruiting? (7)

Shown in this order: the order a trial moves through, from not yet recruiting to unknown.

Trials by recruitment status
Status Trials
Not yet recruiting 1
Recruiting 1
Active, not recruiting 1
Completed 11
Terminated 3

Status as registered on ClinicalTrials.gov. Each trial is counted once.

Which lead sponsors run the most Otosclerosis trials? (3)

Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.

Lead sponsors
Sponsor Trials
Fondation Ophtalmologique Adolphe de Rothschild 3
Carestream Health, Inc. 1
Cochlear 1

Which drugs are being tested for Otosclerosis? (3)

Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.

Drugs tested
Drug Trials
DEXMEDETOMIDINE 1
tiludronic acid 1
Remifentanil 1

Interventions as named in the registry (4)

Shown in this order: most trials first.

Interventions as named in the registry
Drug Trials
Local Anesthetic 1
General anesthetic 1
N Acetylcysteine 1
Radiation 1

These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.

Which publications cover Otosclerosis? (31)

Shown in this order: major-topic papers first, then newest, then most linked to trials.

Publications
Publication Journal Year Major topic
Safety and Effectiveness of the Titanium mAXIS Stapes Prosthesis: Multicentric Short-Term Outcome. Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology 2025 Yes
Binaural squelch effect in unilateral otosclerosis surgery: comparison of speech intelligibility in noise before-after surgery. European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 2022 Yes
Stapedotomy Versus Hearing Aids in the Management of Conductive Hearing Loss Caused by Otosclerosis: A Prospective Comparative Study. Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology 2022 Yes
Endoscopic Stapedotomy: A Systematic Review. Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology 2021 Yes
Measurement of stapes footplate thickness in otosclerosis by ultra-high-resolution computed tomography. Acta oto-laryngologica 2020 Yes

Not on this page

Not measured: delivery record.

Checked, with nothing recorded for this condition: serious adverse events in this condition's trials, prevalence, rare-disease identity, and sub-conditions in mesh.

Browse all condition evidence pages